Source author record

Claes Lundström

Claes Lundström appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Catalog footprint

What is connected

4works
7topics
4close collaborators

Actions

Connect this record

Log in to claim

Research graph

See the researcher in context

Open full explorer

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

4 published item(s)

preprint2022arXiv

Generalisation effects of predictive uncertainty estimation in deep learning for digital pathology

Deep learning (DL) has shown great potential in digital pathology applications. The robustness of a diagnostic DL-based solution is essential for safe clinical deployment. In this work we evaluate if adding uncertainty estimates for DL predictions in digital pathology could result in increased value for the clinical applications, by boosting the general predictive performance or by detecting mispredictions. We compare the effectiveness of model-integrated methods (MC dropout and Deep ensembles) with a model-agnostic approach (Test time augmentation, TTA). Moreover, four uncertainty metrics are compared. Our experiments focus on two domain shift scenarios: a shift to a different medical center and to an underrepresented subtype of cancer. Our results show that uncertainty estimates increase reliability by reducing a model's sensitivity to classification threshold selection as well as by detecting between 70\% and 90\% of the mispredictions done by the model. Overall, the deep ensembles method achieved the best performance closely followed by TTA.

preprint2022arXiv

Learning Representations with Contrastive Self-Supervised Learning for Histopathology Applications

Unsupervised learning has made substantial progress over the last few years, especially by means of contrastive self-supervised learning. The dominating dataset for benchmarking self-supervised learning has been ImageNet, for which recent methods are approaching the performance achieved by fully supervised training. The ImageNet dataset is however largely object-centric, and it is not clear yet what potential those methods have on widely different datasets and tasks that are not object-centric, such as in digital pathology. While self-supervised learning has started to be explored within this area with encouraging results, there is reason to look closer at how this setting differs from natural images and ImageNet. In this paper we make an in-depth analysis of contrastive learning for histopathology, pin-pointing how the contrastive objective will behave differently due to the characteristics of histopathology data. We bring forward a number of considerations, such as view generation for the contrastive objective and hyper-parameter tuning. In a large battery of experiments, we analyze how the downstream performance in tissue classification will be affected by these considerations. The results point to how contrastive learning can reduce the annotation effort within digital pathology, but that the specific dataset characteristics need to be considered. To take full advantage of the contrastive learning objective, different calibrations of view generation and hyper-parameters are required. Our results pave the way for realizing the full potential of self-supervised learning for histopathology applications.

preprint2020arXiv

Survey of XAI in digital pathology

Artificial intelligence (AI) has shown great promise for diagnostic imaging assessments. However, the application of AI to support medical diagnostics in clinical routine comes with many challenges. The algorithms should have high prediction accuracy but also be transparent, understandable and reliable. Thus, explainable artificial intelligence (XAI) is highly relevant for this domain. We present a survey on XAI within digital pathology, a medical imaging sub-discipline with particular characteristics and needs. The review includes several contributions. Firstly, we give a thorough overview of current XAI techniques of potential relevance for deep learning methods in pathology imaging, and categorise them from three different aspects. In doing so, we incorporate uncertainty estimation methods as an integral part of the XAI landscape. We also connect the technical methods to the specific prerequisites in digital pathology and present findings to guide future research efforts. The survey is intended for both technical researchers and medical professionals, one of the objectives being to establish a common ground for cross-disciplinary discussions.

preprint2016arXiv

Scale Stain: Multi-Resolution Feature Enhancement in Pathology Visualization

Digital whole-slide images of pathological tissue samples have recently become feasible for use within routine diagnostic practice. These gigapixel sized images enable pathologists to perform reviews using computer workstations instead of microscopes. Existing workstations visualize scanned images by providing a zoomable image space that reproduces the capabilities of the microscope. This paper presents a novel visualization approach that enables filtering of the scale-space according to color preference. The visualization method reveals diagnostically important patterns that are otherwise not visible. The paper demonstrates how this approach has been implemented into a fully functional prototype that lets the user navigate the visualization parameter space in real time. The prototype was evaluated for two common clinical tasks with eight pathologists in a within-subjects study. The data reveal that task efficiency increased by 15% using the prototype, with maintained accuracy. By analyzing behavioral strategies, it was possible to conclude that efficiency gain was caused by a reduction of the panning needed to perform systematic search of the images. The prototype system was well received by the pathologists who did not detect any risks that would hinder use in clinical routine.